| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |